Estradiol valerate
Activella, Amabelz, Angeliq, Bijuva, Climara, Combipatch, Delestrogen, Depo-testadiol, Ditate, Divigel, Elestrin, Estrace, Estradiol, Estrasorb, Estring, Estrogel, Etyqa, Evamist, Femring, Imvexxy, Ioa, Lunelle, Menostar, Minivelle, Myfembree, Natazia, Prefest, Ryeqo, Vagifem, Vivelle-dot, Zoely (estradiol valerate) is a small molecule pharmaceutical. Estradiol valerate was first approved as Estrace on 1982-01-01. It is used to treat breast neoplasms, hot flashes, hypogonadism, menorrhagia, and premature menopause amongst others in the USA. It has been approved in Europe to treat contraception and leiomyoma.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| activella | New Drug Application | 2023-11-30 |
| afirmelle | ANDA | 2024-09-19 |
| alora | OTC monograph not final | 2019-09-18 |
| altavera | ANDA | 2023-03-02 |
| alyacen 1/35 | ANDA | 2024-05-07 |
| alyacen 1/35 alyacen 7/7/7 | ANDA | 2017-09-08 |
| alyacen 7/7/7 | ANDA | 2023-06-07 |
| amethia | ANDA | 2024-03-01 |
| amethyst | ANDA | 2022-01-31 |
| angeliq | New Drug Application | 2023-12-08 |
Show 269 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
ESTRADIOL / NORETHINDRONE ACETATE / RELUGOLIX, MYFEMBREE, MYOVANT SCIENCES | |||
| 2026-01-27 | M-289 | ||
| 2025-12-18 | NCE | ||
| 2025-08-05 | I-898 | ||
| 2024-05-26 | NP | ||
ESTRADIOL, ESTRADIOL, CHEMO RESEARCH SL | |||
| 2023-04-08 | CGT | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Estradiol / Norethindrone Acetate / Relugolix, Myfembree, Myovant Sciences | |||
| 11793812 | 2038-05-03 | U-2360 | |
| 11033551 | 2037-09-29 | U-3129 | |
| 11795178 | 2033-09-27 | DS, DP | |
| 9346822 | 2024-02-17 | U-3129 | |
| 7300935 | 2024-01-28 | DP | |
| 8058280 | 2024-01-28 | DP | |
| Estradiol, Imvexxy, Mayne Pharma | |||
| 11266661 | 2034-02-02 | U-2316, U-2317 | |
| 9180091 | 2033-12-20 | DP | U-2316, U-2317 |
| 10258630 | 2033-12-20 | U-2316, U-2317 | |
| 10398708 | 2033-12-20 | U-2317, U-2614 | |
| 10471072 | 2033-06-18 | U-2316, U-2317 | |
| 10568891 | 2033-06-18 | U-2316, U-2317 | |
| 10668082 | 2033-06-18 | U-2316, U-2317 | |
| 10888516 | 2033-06-18 | U-2316, U-2317 | |
| 11065197 | 2033-06-18 | DP | |
| 11116717 | 2033-06-18 | DP | |
| 11123283 | 2033-06-18 | DP | |
| 9289382 | 2032-11-21 | DP | |
| 10537581 | 2032-11-21 | DP | U-2316, U-2317 |
| 10806697 | 2032-11-21 | DP | |
| 10835487 | 2032-11-21 | U-2316, U-2317 | |
| 11241445 | 2032-11-21 | U-2316, U-2317 | |
| 11246875 | 2032-11-21 | U-2316, U-2317 | |
| 11304959 | 2032-11-21 | DP | |
| 11351182 | 2032-11-21 | U-2316, U-2317 | |
| 11497709 | 2032-11-21 | U-2316, U-2317 | |
| Estradiol / Progesterone, Bijuva, Mayne Pharma | |||
| 8633178 | 2032-11-21 | DP | |
| 8846648 | 2032-11-21 | U-2439 | |
| 8846649 | 2032-11-21 | DP | U-2439 |
| 8933059 | 2032-11-21 | DP | U-2439 |
| 8987237 | 2032-11-21 | DP | |
| 8993548 | 2032-11-21 | DP | |
| 8993549 | 2032-11-21 | DP | |
| 9006222 | 2032-11-21 | DP | U-2439 |
| 9114145 | 2032-11-21 | U-2439 | |
| 9114146 | 2032-11-21 | DP | U-2439 |
| 9301920 | 2032-11-21 | DP | U-2439 |
| 10052386 | 2032-11-21 | DP | |
| 10206932 | 2032-11-21 | U-2439 | |
| 10639375 | 2032-11-21 | DP | |
| 10675288 | 2032-11-21 | U-2439 | |
| 10806740 | 2032-11-21 | DP | U-2439 |
| 11033626 | 2032-11-21 | DP | U-2439 |
| 11103513 | 2032-11-21 | U-2439 | |
| 11103516 | 2032-11-21 | DP | |
| 11110099 | 2032-11-21 | DP | |
| 11166963 | 2032-11-21 | DP | |
| 11529360 | 2032-11-21 | DP | |
| 11793819 | 2032-11-21 | U-2439 | |
| Drospirenone / Estradiol, Angeliq, Bayer Hlthcare | |||
| 8906890 | 2031-10-22 | DP | |
| Estradiol, Minivelle, Noven | |||
| 8231906 | 2030-07-04 | DS, DP | |
| 9724310 | 2028-07-10 | DS, DP | |
| 9730900 | 2028-07-10 | U-2086 | |
| 9833419 | 2028-07-10 | DP | |
| Dienogest / Estradiol Valerate, Natazia, Bayer Hlthcare | |||
| 8153616 | 2028-01-30 | U-1240 | |
| 8071577 | 2026-05-13 | DP | U-1 |
| Estradiol Acetate, Femtrace, Apil | |||
| 7572779 | 2025-10-02 | U-904 | |
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| J1380 | Injection, estradiol valerate, up to 10 mg |
Clinical
Clinical Trials
1449 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Contraception | D003267 | — | — | 1 | 1 | 11 | 3 | 2 | 18 |
| Menopause | D008593 | EFO_0003922 | N95 | — | — | — | 1 | — | 1 |
| Osteoporosis | D010024 | HP_0000939 | M81.0 | — | — | — | 1 | — | 1 |
| Postmenopause | D017698 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dysmenorrhea | D004412 | HP_0100607 | N94.6 | — | 1 | 2 | — | — | 3 |
| Physiological sexual dysfunction | D012735 | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Uterine hemorrhage | D014592 | — | — | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infertility | D007246 | HP_0000789 | — | 1 | — | — | — | — | 1 |
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 2 | 2 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 1 | 1 |
| Pharmacokinetics | D010599 | — | — | — | — | — | — | 1 | 1 |
| Metrorrhagia | D008796 | HP_0100608 | N92.1 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Estradiol valerate |
| INN | estradiol valerate |
| Description | Estradiol valerate is a steroid ester. |
| Classification | Small molecule |
| Drug class | estrogens |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C |
Identifiers
| PDB | — |
| CAS-ID | 979-32-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1511 |
| ChEBI ID | 31561 |
| PubChem CID | 13791 |
| DrugBank | DB13956 |
| UNII ID | OKG364O896 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Estradiol – Amneal Pharmaceuticals
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Bijuva – TherapeuticsMD
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Imvexxy – TherapeuticsMD
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Ryeqo – Myovant Sciences
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Divigel – RVL Pharmaceuticals
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Myfembree – Myovant Sciences
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 38,863 documents
View more details
Safety
Black-box Warning
Black-box warning for: Activella, Altavera, Amethia, Angeliq, Annovera, Ashlyna, Aurovela 1.5/30, Aurovela 24 fe, Ayuna, Azurette, Balcoltra, Bekyree, Beyaz, Bijuva, Blisovi 24 fe, Blisovi fe 1.5/30, Blisovi fe 1/20, Camrese, Camrese lo, Camreselo, Charlotte 24fe, Chateal eq, Climara, Climara pro, Climarapro, Combipatch (estradiol/norethindrone acetate transdermal system), Cryselle, Cyclafem 1/35, Cyclafem 7/7/7, Cyonanz, Cyred eq, Dasetta 1/35, Dasetta 7/7/7, Daysee, Delestrogen, Depo-estradiol, Desogestrel and ethinyl estradiol, Divigel, Dotti, Drospirenone and ethinyl estradiol, Drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium, Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium, Elestrin, Elinest, Eluryng, Enilloring, Enskyce, Estarylla, Estra-25 estra-50, Estrace, Estradiol, Estradiol / norethindrone acetate, Estradiol and norethindrone acetate, Estradiol and progesterone, Estradiol transdermal system, Estradiol vaginal, Estradiol vaginal cream, Estradiol vaginal inserts, Estradiol valerate, Estradiol valerate and estradiol valerate/dienogest, Estring, Estrogel, Etonogestrel and ethinyl estradiol, Etonogestrel and ethinyl estradiol vaginal, Etonogestrel and ethinyl estradiol vaginal ring, Etonogestrel/ethinyl estradiol, Etyqa, Evamist, Femhrt, Femlyv, Femring, Femynor, Finzala, Fyavolv, Gemmily, Hailey 1.5/30, Hailey 24 fe, Hailey fe 1.5/30, Hailey fe 1/20, Haloette, Iclevia, Imvexxy, Introvale, Isibloom, Jaimiess, Jasmiel, Jinteli, Jolessa, Joyeaux, Juleber, Junel, Junel fe, Junel fe 1/20, Kaitlib fe, Kalliga, Kariva, Kurvelo, Larin 1.5/30, Larin 1/20, Larin 24 fe, Larin fe 1/20, Layolis fe, Levonorgestrel and ethinyl estradiol, Levonorgestrel and ethinyl estradiol and ethinyl estradiol, Levonorgestrel/ethinyl estradiol and ethinyl estradiol, Levora, Lo loestrin fe, Lo simpesse, Lo-zumandimine, Loestrin, Loestrin 24 fe, Lojaimiess, Lopreeza, Loryna, Loseasonique, Low-ogestrel, Lyllana, Marlissa, Melodetta 24 fe, Menostar, Merzee, Mibelas 24 fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin 24 fe, Microgestin fe 1/20, Mili, Mimvey, Mimvey mimvey lo, Minivelle, Minzoya, Mono-linyah, Mononessa, Myfembree, Myzilra, Natazia, Necon, Nexesta fe, Nikki, Norelgestromin and ethinly estradiol, Norelgestromin and ethinyl estradiol, Norethindrone acetate and ethinyl estradiol, Norethindrone acetate and ethinyl estradiol and ferrous fumarate, Norethindrone acetate and ethinyl estradiol, and ferrous fumarate, Norethindrone and ethinyl estradiol, Norethindrone and ethinyl estradiol and ferrous fumarate, Norgestimate and ethinyl estradiol, Nuvaring, Nylia 1/35, Nylia 7/7/7, Nymyo, Ocella, Oriahnn, Ortho tri-cyclen lo, Oshih, Portia, Previfem, Quartette, Rivelsa, Safyral, Seasonique, Setlakin, Simliya, Simpesse, Sprintec, Syeda, Tarina 24 fe, Taysofy, Taytulla, Tilia fe, Tri femynor, Tri-estarylla, Tri-legest fe, Tri-linyah, Tri-lo- estarylla, Tri-lo-marzia, Tri-lo-mili, Tri-lo-sprintec, Tri-mili, Tri-nymyo, Tri-sprintec, Tri-vylibra, Tri-vylibra lo, Trinessa, Turqoz, Twirla, Tyblume, Tydemy, Vagifem, Vestura, Viorele, Vivelle dot, Vivelle-dot, Vylibra, Wera, Wymzya fe, Xulane, Yasmin, Yaz, Yuvafem, Zafemy, Zarah, Zenchent fe, Zumandimine
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
105,148 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use